Literature DB >> 12189406

Predictors of refractory tachycardia in infants with supraventricular tachycardia.

S Sanatani1, R M Hamilton, G J Gross.   

Abstract

Reentrant supraventricular tachycardia (SVT) is the most common arrhythmia in infants. There are few predictors as to which patients will have recurrent or refractory SVT. We retrospectively reviewed records of all infants with SVT evaluated at The Hospital for Sick Children, Toronto, between January 1, 1995, and December 31, 1999. Patients with reentrant SVT documented in infancy and structurally normal hearts were included. Patients were placed in two groups: the "simple" group consisted of patients with SVT completely controlled by not more than one medication, and the "complex" group consisted of patients with recurrent episodes requiring at least one medication change for control. Forty-two cases were analyzed-23 in the simple group and 19 in the complex group. One patient in each group died. Age at presentation was 50.4 +/- 13.2 days for the simple group versus 10.2 +/- 2.5 days for the complex group (p <0.01). Complex patients were treated with a median of three medications and were more likely to have echocardiographically reduced ventricular function. The surface electrocardiogram RP interval during SVT was significantly longer in complex patients (p <0.001). There were no differences between the groups in gender, cycle length in SVT or sinus rhythm, the presence of pre-excitation, initial medication choice, or duration of therapy. Recurrent SVT in infancy is associated with younger age and/or ventricular dysfunction at presentation and also with slower ventriculoatrial conduction. The similar duration of therapy for simple and complex patients suggests that the early clinical course of SVT in infancy is not predictive of long-term outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12189406     DOI: 10.1007/s00246-002-1514-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  5 in total

1.  Medications used to manage supraventricular tachycardia in the infant a North American survey.

Authors:  K K Wong; J E Potts; S P Etheridge; S Sanatani
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

2.  Nadolol for Treatment of Supraventricular Tachycardia in Infants and Young Children.

Authors:  Johannes C von Alvensleben; Martin J LaPage; Regine Caruthers; David J Bradley
Journal:  Pediatr Cardiol       Date:  2016-12-19       Impact factor: 1.655

3.  The medical management of pediatric arrhythmias.

Authors:  Carolina Escudero; Roxane Carr; Shubhayan Sanatani
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-10

4.  Radiofrequency catheter ablation in children with supraventricular tachycardias: intermediate term follow up results.

Authors:  Mm Hafez; Mm Abu-Elkheir; M Shokier; Hf Al-Marsafawy; Hm Abo-Haded; M Abo El-Maaty
Journal:  Clin Med Insights Cardiol       Date:  2012-01-05

Review 5.  Neonatal supraventricular tachyarrhythmias, approach and treatment from pathophysiology

Authors:  Keerby Hernández; Ángela Hoyos; Lina P Montana; María J Castellanos; Isabel Sánchez
Journal:  Arch Cardiol Mex       Date:  2022-04-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.